Sun Pharma inks global licensing deal with LIB Therapeutics for bad cholesterol treatment drug

Shares of Sun Pharmaceutical Industries Ltd. are in focus on Monday, September 28, after it announced licensing, commericalisation and manufacturing agreement with LIB Tehrapeutics for a bad cholesterol treatment drug known as lerodalcibep.Lerodalcibep is approved in the EU under the brand name Lyr…